$富途控股(FUTU.US$ 终于上去了~
已翻译
1
Sky Investment
留下了心情
At the close on the last trading day, the Dow Jones Industrial Average lost 0.78%, while the S&P 500 index fell 0.77%, and the NASDAQ Composite index lost 0.87%.
The Post Labor Day IPO storm is coming this week. Several IPOs will be listed such asTech consultancy $Thoughtworks(TWKS.US$, Swiss running shoe brand $昂跑(ONON.US$, $Dutch Bros(BROS.US$.
On the last trading day, there were three traditional IPOs filed while no new stock officially listed for trading.
Exscientia, an Oxford, United Kingdom-based company founded in 2012, provides an AI-driven platform for drug design, discovery, and development. It aims to discover, design, and develop the best possible drugs in the fastest and most effective manner.
The company has built a complete end-to-end solution of AI and experimental technologies for target identification, drug candidate design, translational models, and patient selection.
It has originated the first three AI-designed precision drug candidates to enter human clinical trials. Its most advanced internally developed candidate, EXS21546, began a Phase 1 trial in December 2020. The other two candidates, are also currently in Phase 1 trials.
$Nuvalent(NUVL.US$, founded in 2017, is a preclinical oncology biotech developing small molecule kinase inhibitors.
Nuvalent focuses on clinically proven kinase targets that have demonstrated efficacy and received FDA approval. It seeks to improve upon the limitations of existing kinase inhibitors, including kinase resistance, selectivity, and limited brain penetrance.
The company's lead product, NVL-520, is a brain-penetrant ROS1-selective inhibitor and is expected to begin clinical trials in patients with ROS1-positive non-small cell lung cancer and other advanced solid tumors in the second half of 2021, pending the acceptance of its IND.
Nuvalent began trading on July 29, 2021. As of September 11th, it has a market cap of $1.83 billion, with the listed to date gain of 122.76%.
The Post Labor Day IPO storm is coming this week. Several IPOs will be listed such asTech consultancy $Thoughtworks(TWKS.US$, Swiss running shoe brand $昂跑(ONON.US$, $Dutch Bros(BROS.US$.
On the last trading day, there were three traditional IPOs filed while no new stock officially listed for trading.
Exscientia, an Oxford, United Kingdom-based company founded in 2012, provides an AI-driven platform for drug design, discovery, and development. It aims to discover, design, and develop the best possible drugs in the fastest and most effective manner.
The company has built a complete end-to-end solution of AI and experimental technologies for target identification, drug candidate design, translational models, and patient selection.
It has originated the first three AI-designed precision drug candidates to enter human clinical trials. Its most advanced internally developed candidate, EXS21546, began a Phase 1 trial in December 2020. The other two candidates, are also currently in Phase 1 trials.
$Nuvalent(NUVL.US$, founded in 2017, is a preclinical oncology biotech developing small molecule kinase inhibitors.
Nuvalent focuses on clinically proven kinase targets that have demonstrated efficacy and received FDA approval. It seeks to improve upon the limitations of existing kinase inhibitors, including kinase resistance, selectivity, and limited brain penetrance.
The company's lead product, NVL-520, is a brain-penetrant ROS1-selective inhibitor and is expected to begin clinical trials in patients with ROS1-positive non-small cell lung cancer and other advanced solid tumors in the second half of 2021, pending the acceptance of its IND.
Nuvalent began trading on July 29, 2021. As of September 11th, it has a market cap of $1.83 billion, with the listed to date gain of 122.76%.
![IPO Recap: AI Drug discovery platform Exscientia files for IPO](https://ussnsimg.moomoo.com/1094172575827655077.png/thumb)
![IPO Recap: AI Drug discovery platform Exscientia files for IPO](https://ussnsimg.moomoo.com/4397763095558170922.png/thumb)
![IPO Recap: AI Drug discovery platform Exscientia files for IPO](https://ussnsimg.moomoo.com/4679930824015742479.png/thumb)
+1
4
Sky Investment
评论了
对于初学者来说,下订单有时可能是一项艰巨的任务。
在本视频中,我们将指导您如何下市价/限价单。
关注我们获取更多教程。
如需更多指南,请参阅 moomoo 课程,网址为 https://live.moomoo.com/college
在moomoo上享受财务之旅的乐趣!
$AMC院线(AMC.US$ $特斯拉(TSLA.US$ $标普500指数(.SPX.US$ $SPDR 标普500指数ETF(SPY.US$ $纳斯达克综合指数(.IXIC.US$
在本视频中,我们将指导您如何下市价/限价单。
关注我们获取更多教程。
如需更多指南,请参阅 moomoo 课程,网址为 https://live.moomoo.com/college
$AMC院线(AMC.US$ $特斯拉(TSLA.US$ $标普500指数(.SPX.US$ $SPDR 标普500指数ETF(SPY.US$ $纳斯达克综合指数(.IXIC.US$
已翻译
![[视频教程] 如何在 moomoo 上下订单?](https://ussnsimg.moomoo.com/202106170000078178e2dd5e936.jpg/thumb)
6131
6913